89: An interview with Damon Race, CEO of GeneVentive Therapeutics
Episode Ep 89 13 min 30s

89: An interview with Damon Race, CEO of GeneVentive Therapeutics

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Damon Race, CEO of GeneVentive Therapeutics. The North Carolina-based startup hopes to develop a universal gene therapy that will benefit hemophilia A and B patients with inhibitors.

Community discussion